Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Am J Psychiatry. 2021 Jun 3;178(9):818–828. doi: 10.1176/appi.ajp.2020.20070993

Figure 2.

Figure 2.

Percentage of participants in each medication group, VAR + PLAC and VAR + NTX, who quit smoking (bioverified by CO reading of ≤ 5 ppm) at the 26-week assessment. Smoking abstinence at week 26 was significantly higher in the VAR + PLAC condition than the VAR + NTX condition (χ2[1] = 6.22, p=.015).